Scientific leader versed in leveraging AI to strategically develop and implement translational and discovery research. Currently Vice President Artificial Intelligence Drug Discovery at BioXcel Therapeutics. Expertise in leading international cross functional teams to build enabling platforms that leverage Artificial Intelligence throughout the value chain. Implemented wearable technology, signal processing and data analytics to inform clinical trials, innovate healthcare and quantify clinical outcome measures. Skilled at developing business strategies and alliances to create sustainable growth. Strong scientific background in neuroscience target areas with expertise in neurodevelopmental disorders, autism spectrum disorders and retina.https://www.drugdiscoverytrends.com/bioxcel-ai-platform-drug-repurposing-neuropsychiatric-disorders/https://www.linkedin.com/feed/update/urn:li:activity:7207445574839586816/
Listed skills include Molecular Biology, In Vivo, In Vitro, Animal Models, and 16 others.